Literature DB >> 10691174

Cardiac rupture and admission electrocardiography in acute anterior myocardial infarction: implication of ST elevation in aVL.

H Yoshino1, M Yotsukura, K Yano, M Taniuchi, E Kachi, H Shimizu, H Udagawa, T Kajiwara, K Ishikawa.   

Abstract

This study determines the usefulness of electrocardiography in the emergency room for assessing the risk of cardiac rupture after acute anterior myocardial infarction (MI). The presence of ST segment elevation on the admission 12-lead electrocardiography was evaluated in 325 consecutive anterior MI patients. A forward-stepwise logistic regression analysis for cardiac rupture was performed with the covariates of age, gender, hypertension, history of MI, reperfusion therapy by coronary angioplasty, and ST segment elevations in leads I, aVL, V1-V6. Cardiac rupture occurred in 16 patients, including 7 with left ventricular free wall rupture (FWR) and 9 with ventricular septal perforation (VSP). For FWR, ST elevation in lead aVL was the only independent predictor (odds ratio = 12.1, P = .0215). For VSP, female gender (odds ratio = 5.32, P = .0201) was the independent predictor. In conclusion, in patients with acute anterior MI, ST segment elevation in lead aVL on the admission electrocardiography is a significant risk factor for left ventricular FWR.

Entities:  

Mesh:

Year:  2000        PMID: 10691174     DOI: 10.1016/s0022-0736(00)80100-4

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Impending myocardial rupture: is an early surgical treatment enough?

Authors:  Davide Lanzellotti; Filippo Marzot; Cosimo Guglielmi; Marco Panfili
Journal:  BMJ Case Rep       Date:  2011-09-19

2.  Case 02/2015 - A 67 Year-Old Woman with Sudden Cardiogenic Shock in the 7th Day after Acute Myocardial Infarction.

Authors:  Bruno Aguiar Pinheiro; Alice Tatsuko Yamada; Vera Demarchi Aiello
Journal:  Arq Bras Cardiol       Date:  2015-07-01       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.